Evidence map›Paper›PMID 41586501›Full record

ArticleAntimicrobial agents and chemotherapy2026

Putative azithromycin resistance mutations in

Parul Sharma, Deborah Dean, Timothy D Read

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Parul SharmaDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0002-3065-4377
Deborah DeanDivision of Infectious Diseases and Global Health, Departments of Medicine and Pediatrics, University of California San Francisco School of Medicine, San Francisco, California, USA.ORCID 0000-0002-4490-1746
Timothy D ReadDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0001-8966-9680

Funding

Natural History of C. trachomatis urogenital and rectal infectionsR01AI151075 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEAN, DEBORAH ANNE, READ, TIMOTHY D. · 2020 to 2024
$4.0M
Impact of ocular microbiome, immune response and Chlamydiae on trachoma following MDAR01AI158527 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEBORAH Anne DEAN, Timothy D. Read · 2022 to 2026
$4.0M
NIAID NIH HHS R01 AI151075NIAID NIH HHS R01 AI158527NIH HHS AI158527NIH HHS AI51075
6 · The paper itself

Abstract

Azithromycin is widely used to treat

Indexed as

Anti-Bacterial AgentsAzithromycinChlamydia trachomatisDrug Resistance, BacterialMutationChlamydia InfectionsHumansMicrobial Sensitivity TestsPhylogenyRNA, Ribosomal, 23SAnti-Bacterial AgentsAzithromycinRNA, Ribosomal, 23Santimicrobial resistanceazithromycinChlamydia trachomatisgenomic surveillance

Identifiers

PMID41586501
PMCPMC12959087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.